In conclusion, hnf1a expression can reflect resistance to anticancer drug treatment, and its suppression improves anticancer drug sensitivity as a new therapeutic target. We demonstrated that triptolide directly bound to hnf1a, one of the transcription factors of shh, and inhibited hnf1a/shh expression, ensuing in attenuation of hedgehog signaling.